Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Pharma (IGC) over the last 12 years, with Q3 2025 value amounting to $90.5 million.

  • Pharma's Shares Outstanding (Diluted Average) rose 1901.24% to $90.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.5 million, marking a year-over-year increase of 1901.24%. This contributed to the annual value of $76.5 million for FY2025, which is 3004.31% up from last year.
  • Latest data reveals that Pharma reported Shares Outstanding (Diluted Average) of $90.5 million as of Q3 2025, which was up 1901.24% from $83.0 million recorded in Q2 2025.
  • Over the past 5 years, Pharma's Shares Outstanding (Diluted Average) peaked at $90.5 million during Q3 2025, and registered a low of $54.3 million during Q3 2023.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $72.6 million, with a median of $76.0 million in 2024.
  • Per our database at Business Quant, Pharma's Shares Outstanding (Diluted Average) skyrocketed by 3997.35% in 2024 and then skyrocketed by 1402.7% in 2025.
  • Quarter analysis of 3 years shows Pharma's Shares Outstanding (Diluted Average) stood at $63.7 million in 2023, then rose by 21.82% to $77.6 million in 2024, then increased by 16.52% to $90.5 million in 2025.
  • Its last three reported values are $90.5 million in Q3 2025, $83.0 million for Q2 2025, and $76.5 million during Q1 2025.